12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Company News  |  Deals

Genta, Relgen LLC deal

GNTA will acquire Relgen's rights and assets related to a portfolio of gallium-containing compounds used to treat disorders associated...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >